Douglas Lane & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$496K Sell
1,823
-82
-4% -$23.1K 0.01% 187
2026
Q2
$525K Sell
1,905
-31
-2% -$8.76K 0.01% 188
2026
Q1
$516K Hold
1,936
– – 0.01% 180
2025
Q4
$533K Sell
1,936
-80
-4% -$22.4K 0.01% 177
2025
Q3
$581K Sell
2,016
-22
-1% -$6.51K 0.01% 172
2025
Q2
$674K Buy
2,038
+344
+20% +$111K 0.01% 166
2025
Q1
$557K Buy
1,694
+58
+4% +$17.5K 0.01% 177
2024
Q4
$452K Buy
1,636
+56
+4% +$17.9K 0.01% 185
2024
Q3
$547K Sell
1,580
-53
-3% -$18.2K 0.01% 181
2024
Q2
$540K Sell
1,633
-152
-9% -$52.4K 0.01% 177
2024
Q1
$648K Buy
+1,785
New +$588K 0.01% 173

Other funds holding CI

Douglas Lane & Associates's CI Position: Q3 2026 in Review

Douglas Lane & Associates reduced its Cigna (CI) stake by 4.3% in Q3 2026, selling an estimated $23.1K and leaving 1,823 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #187.

Douglas Lane & Associates first reported a position in CI in Q1 2024 and has held it in 11 quarters since. The position peaked at $674K in Q2 2025. 66 funds tracked by Wall St. Rank hold CI as of Q3 2026.

  • Douglas Lane & Associates held 1,823 shares of Cigna worth $496K as of Q3 2026.
  • Douglas Lane & Associates sold 82 Cigna shares in Q3 2026, an estimated $23.1K.
  • Cigna made up 0.01% of Douglas Lane & Associates's portfolio in Q3 2026, its #187 holding.
  • Douglas Lane & Associates first reported a position in Cigna in Q1 2024 and has held it in 11 quarters since.
  • Douglas Lane & Associates's Cigna position peaked at $674K in Q2 2025.
  • 66 funds tracked by Wall St. Rank held Cigna as of Q3 2026.

Based on Douglas Lane & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.